Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-08
DOI
10.1038/s41467-019-11396-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
- (2019) Pavlina Chuntova et al. Frontiers in Immunology
- The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review
- (2019) Jianxiang Zhang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Drug hypersensitivity: We need to do more
- (2018) Werner J. Pichler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
- (2018) Chuang-Wei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- A transgenic mouse model for HLA-B*57:01–linked abacavir drug tolerance and reactivity
- (2018) Marco Cardone et al. JOURNAL OF CLINICAL INVESTIGATION
- The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
- (2018) Wei-Ti Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors
- (2018) Yong-Chen Lu et al. MOLECULAR THERAPY
- Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+T Cells in Peripheral Blood of Subjects with Type 1 Diabetes
- (2017) Karen Cerosaletti et al. JOURNAL OF IMMUNOLOGY
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells: Table 1.
- (2016) Hiroaki Ikeda INTERNATIONAL IMMUNOLOGY
- Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
- (2016) Chun-Bing Chen et al. NEUROLOGY
- Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction
- (2015) Chia-Hsien Lin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response
- (2015) Katie D. White et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions
- (2015) Wen-Hung Chung et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Allopurinol Use and Risk of Fatal Hypersensitivity Reactions
- (2015) Chien-Yi Yang et al. JAMA Internal Medicine
- Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
- (2014) Wen-Hung Chung et al. ANNALS OF THE RHEUMATIC DISEASES
- Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions
- (2014) Wen-Hung Chung et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- In vitro expansion of antigen-specific CD8+ T cells distorts the T-cell repertoire
- (2014) Dan Koning et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Linking T-cell receptor sequence to functional phenotype at the single-cell level
- (2014) Arnold Han et al. NATURE BIOTECHNOLOGY
- A Molecular Basis for the Control of Preimmune Escape Variants by HIV-Specific CD8+ T Cells
- (2013) Kristin Ladell et al. IMMUNITY
- A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders
- (2013) Chuang-Wei Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses
- (2013) R. Boucherma et al. JOURNAL OF IMMUNOLOGY
- HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
- (2013) F.-R. Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sulfamethoxazole Induces a Switch Mechanism in T Cell Receptors Containing TCRVβ20-1, Altering pHLA Recognition
- (2013) Stephan Watkins et al. PLoS One
- Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display
- (2013) Kristin S. Gunnarsen et al. Scientific Reports
- Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury
- (2012) Manal M. Monshi et al. HEPATOLOGY
- Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
- (2012) Chun-Yu Wei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients
- (2012) Nao Saito et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis
- (2012) Wen-Hung Chung et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
- (2012) Patricia T. Illing et al. NATURE
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
- (2012) D. A. Ostrov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune pathomechanism of drug hypersensitivity reactions
- (2011) Werner J. Pichler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
- (2011) Tai-Ming Ko et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structure-Based Selection of Small Molecules To Alter Allele-Specific MHC Class II Antigen Presentation
- (2011) A. W. Michels et al. JOURNAL OF IMMUNOLOGY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Interleukin-17 and its expanding biological functions
- (2010) Sheng Xu et al. Cellular & Molecular Immunology
- ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
- (2010) B Sassolas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- fpocket: online tools for protein ensemble pocket detection and tracking
- (2010) P. Schmidtke et al. NUCLEIC ACIDS RESEARCH
- High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets
- (2010) C. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Markers and Danger Signals in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- (2010) Wen-Hung Chung et al. ALLERGOLOGY INTERNATIONAL
- Fpocket: An open source platform for ligand pocket detection
- (2009) Vincent Le Guilloux et al. BMC BIOINFORMATICS
- Germline-encoded amino acids in the αβ T-cell receptor control thymic selection
- (2009) James P. Scott-Browne et al. NATURE
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2008) Wen-Hung Chung et al. NATURE MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The p-i Concept
- (2008) Werner J. Pichler World Allergy Organization Journal
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started